Endovascular Engineering raised $42 million in a Series B round co-led by 415 Capital and S3 Ventures to advance its clot removal technology for pulmonary embolism.
Amount Raised
$42 Million
Round Type
Series B
Menlo ParkBiotechnologyHealth CareMedical Devicemedical devicesInvestors
Description
Endovascular Engineering, Inc. has secured $42 million in an oversubscribed Series B financing to advance its next generation clot removal technology platform for venous thromboembolism. The additional capital strengthens E2's position to address critical unmet needs in interventional medicine while pursuing a new standard of care.
Quick answer
Endovascular Engineering raised $42 Million in a Series B round, dated February 18, 2025. Investors: Panakès Partners, M&L Healthcare, Santé Ventures, Cordis, 415 Capital and S3 Ventures. Endovascular Engineering is based in Menlo Park, California, United States.
- How much did Endovascular Engineering raise?
- Endovascular Engineering raised $42 Million in a Series B round on February 18, 2025.
- Who invested in Endovascular Engineering?
- Panakès Partners, M&L Healthcare, Santé Ventures, Cordis, 415 Capital and S3 Ventures are named as investors in this round.
- What does Endovascular Engineering do?
- Endovascular Engineering, Inc. ("E2") is at the forefront of transforming venous thromboembolism (VTE) treatment with the Hēlo™ Thrombectomy System, a novel technology designed for the treatment of pulmonary embolism.
- Where is Endovascular Engineering based and how big is it?
- Endovascular Engineering is based in Menlo Park, California, United States. Fundz records about 37 employees.
- Who are the decision-makers at Endovascular Engineering?
- Fundz holds 1 contact at Endovascular Engineering. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical Device and medical devices around the same time
Companies in the same sectors as Endovascular Engineering that raised within 45 days of this round, from Fundz verified event records.
- CMR Surgical raised $200M on April 2, 2025.
- MED-X raised $428K on January 23, 2025.
- Cornerstone Robotics raised $70M (Series C) on January 13, 2025.
- Perkant Tech raised $772K (Seed) on April 3, 2025.
- Tenon Medical raised $2.5M on March 25, 2025.
- Tenon Medical raised $1.5M on March 25, 2025.
Who to call at Endovascular Engineering, and when
A new round usually means Endovascular Engineering is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Endovascular Engineering raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Endovascular Engineering, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Endovascular Engineering. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Endovascular Engineering raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansEndovascular Engineering raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.